397 related articles for article (PubMed ID: 37600822)
1. Nanoparticle-based drug delivery systems to enhance cancer immunotherapy in solid tumors.
Zhang J; Wang S; Zhang D; He X; Wang X; Han H; Qin Y
Front Immunol; 2023; 14():1230893. PubMed ID: 37600822
[TBL] [Abstract][Full Text] [Related]
2. Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy.
Lim S; Park J; Shim MK; Um W; Yoon HY; Ryu JH; Lim DK; Kim K
Theranostics; 2019; 9(25):7906-7923. PubMed ID: 31695807
[TBL] [Abstract][Full Text] [Related]
3. Advances in tumor immunomodulation based on nanodrug delivery systems.
Wang B; Zhang Y; Yin X
Front Immunol; 2023; 14():1297493. PubMed ID: 38106403
[TBL] [Abstract][Full Text] [Related]
4. A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors.
Qian X; Shi Z; Qi H; Zhao M; Huang K; Han D; Zhou J; Liu C; Liu Y; Lu Y; Yuan X; Zhao J; Kang C
Theranostics; 2019; 9(25):7616-7627. PubMed ID: 31695790
[TBL] [Abstract][Full Text] [Related]
5. Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics.
Zhou L; Zou M; Xu Y; Lin P; Lei C; Xia X
Front Oncol; 2022; 12():864301. PubMed ID: 35664731
[TBL] [Abstract][Full Text] [Related]
6. Advanced Generation Therapeutics: Biomimetic Nanodelivery System for Tumor Immunotherapy.
Li J; Zeng H; Li L; Yang Q; He L; Dong M
ACS Nano; 2023 Dec; 17(24):24593-24618. PubMed ID: 38055350
[TBL] [Abstract][Full Text] [Related]
7. Tumor microenvironment responsive metal nanoparticles in cancer immunotherapy.
Yang R; Chen L; Wang Y; Zhang L; Zheng X; Yang Y; Zhu Y
Front Immunol; 2023; 14():1237361. PubMed ID: 37575228
[TBL] [Abstract][Full Text] [Related]
8. Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy.
Wang HL; Wang ZG; Liu SL
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080373
[TBL] [Abstract][Full Text] [Related]
9. Research progress in nano-drug delivery systems based on the characteristics of the liver cancer microenvironment.
Lu S; Zhang C; Wang J; Zhao L; Li G
Biomed Pharmacother; 2024 Jan; 170():116059. PubMed ID: 38154273
[TBL] [Abstract][Full Text] [Related]
10. Smart Nanosized Drug Delivery Systems Inducing Immunogenic Cell Death for Combination with Cancer Immunotherapy.
Zhou L; Zhang P; Wang H; Wang D; Li Y
Acc Chem Res; 2020 Sep; 53(9):1761-1772. PubMed ID: 32819102
[TBL] [Abstract][Full Text] [Related]
11. Nano-sized drug delivery systems to potentiate the immune checkpoint blockade therapy.
Shim MK; Song SK; Jeon SI; Hwang KY; Kim K
Expert Opin Drug Deliv; 2022 Jun; 19(6):641-652. PubMed ID: 35603410
[TBL] [Abstract][Full Text] [Related]
12. Charge-switchable nanoparticles enhance Cancer immunotherapy based on mitochondrial dynamic regulation and immunogenic cell death induction.
Zhao M; Li J; Liu J; Xu M; Ji H; Wu S; Chen D; Hu H
J Control Release; 2021 Jul; 335():320-332. PubMed ID: 34062192
[TBL] [Abstract][Full Text] [Related]
13. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
Nakamura T
Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
[TBL] [Abstract][Full Text] [Related]
14. Recent advances of nanodrug delivery system in the treatment of hematologic malignancies.
Ye Q; Lin Y; Li R; Wang H; Dong C
Semin Cancer Biol; 2022 Nov; 86(Pt 2):607-623. PubMed ID: 35339668
[TBL] [Abstract][Full Text] [Related]
15. Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview.
Liu X; Cheng Y; Mu Y; Zhang Z; Tian D; Liu Y; Hu X; Wen T
Front Immunol; 2024; 15():1328145. PubMed ID: 38298192
[TBL] [Abstract][Full Text] [Related]
16. Advances in the variations and biomedical applications of stimuli-responsive nanodrug delivery systems.
Gong Z; Peng S; Cao J; Tan H; Zhao H; Bai J
Nanotechnology; 2024 Jan; 35(13):. PubMed ID: 38198449
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle-Mediated Remodeling of the Tumor Microenvironment to Enhance Immunotherapy.
Musetti S; Huang L
ACS Nano; 2018 Dec; 12(12):11740-11755. PubMed ID: 30508378
[TBL] [Abstract][Full Text] [Related]
18. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
19. DNAzyme-Assisted Nano-Herb Delivery System for Multiple Tumor Immune Activation.
Du S; Chen C; Qu S; Song H; Yang J; Li Y; Liu K; Lu Q; Luo W; Wang R; Guan X; Song Y; Han X
Small; 2022 Nov; 18(45):e2203942. PubMed ID: 36156383
[TBL] [Abstract][Full Text] [Related]
20. Engineered Nanoparticles for Cancer Vaccination and Immunotherapy.
Aikins ME; Xu C; Moon JJ
Acc Chem Res; 2020 Oct; 53(10):2094-2105. PubMed ID: 33017150
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
